These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 31820685

  • 21. Visfatin -948G/T and resistin -420C/G polymorphisms in Egyptian type 2 diabetic patients with and without cardiovascular diseases.
    Motawi TM, Shaker OG, El-Sawalhi MM, Abdel-Nasser ZM.
    Genome; 2014 May; 57(5):259-66. PubMed ID: 25120107
    [Abstract] [Full Text] [Related]

  • 22. Association of ADIPOQ, leptin, LEPR, and resistin polymorphisms with obesity parameters in Hammam Sousse Sahloul Heart Study.
    Zayani N, Omezzine A, Boumaiza I, Achour O, Rebhi L, Rejeb J, Ben Rejeb N, Ben Abdelaziz A, Bouslama A.
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28195351
    [Abstract] [Full Text] [Related]

  • 23. Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study.
    Hivert MF, Manning AK, McAteer JB, Dupuis J, Fox CS, Cupples LA, Meigs JB, Florez JC.
    Diabetes; 2009 Mar; 58(3):750-6. PubMed ID: 19074981
    [Abstract] [Full Text] [Related]

  • 24. Adipokine Gene Single-Nucleotide Polymorphisms in Portuguese Obese Adolescents: Associations with Plasma Concentrations of Adiponectin, Resistin, IL-6, IL-1β, and TNF-α.
    Nascimento H, Vieira E, Coimbra S, Catarino C, Costa E, Bronze-da-Rocha E, Rocha-Pereira P, Carvalho M, Ferreira Mansilha H, Rêgo C, Dos Santos R, Santos-Silva A, Belo L.
    Child Obes; 2016 Aug; 12(4):300-13. PubMed ID: 27159547
    [Abstract] [Full Text] [Related]

  • 25. Genetic variants of resistin and its plasma levels: Association with obesity and dyslipidemia related to type 2 diabetes susceptibility.
    Rathwa N, Patel R, Palit SP, Ramachandran AV, Begum R.
    Genomics; 2019 Jul; 111(4):980-985. PubMed ID: 29969661
    [Abstract] [Full Text] [Related]

  • 26. Association of -394C>G and -420C>G polymorphisms in the RETN gene with T2DM and CHD and a new potential SNP might be exist in exon 3 of RETN gene in Chinese.
    Chi S, Lan C, Zhang S, Liu H, Wang X, Chen Y, Chen X, Chen S, Zhang W.
    Mol Cell Biochem; 2009 Oct; 330(1-2):31-8. PubMed ID: 19381781
    [Abstract] [Full Text] [Related]

  • 27. Common quantitative trait locus downstream of RETN gene identified by genome-wide association study is associated with risk of type 2 diabetes mellitus in Han Chinese: a Mendelian randomization effect.
    Chung CM, Lin TH, Chen JW, Leu HB, Yin WH, Ho HY, Sheu SH, Tsai WC, Chen JH, Lin SJ, Pan WH.
    Diabetes Metab Res Rev; 2014 Mar; 30(3):232-40. PubMed ID: 24123702
    [Abstract] [Full Text] [Related]

  • 28. Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study.
    Xu JY, Sham PC, Xu A, Tso AW, Wat NM, Cheng KY, Fong CH, Janus ED, Lam KS.
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):211-7. PubMed ID: 17223990
    [Abstract] [Full Text] [Related]

  • 29. Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction.
    Norata GD, Ongari M, Garlaschelli K, Tibolla G, Grigore L, Raselli S, Vettoretti S, Baragetti I, Noto D, Cefalù AB, Buccianti G, Averna M, Catapano AL.
    J Intern Med; 2007 Jul; 262(1):104-12. PubMed ID: 17598818
    [Abstract] [Full Text] [Related]

  • 30. Association of the resistin gene promoter region polymorphism with Kawasaki disease in Chinese children.
    Liu R, He B, Gao F, Liu Q, Yi Q.
    Mediators Inflamm; 2012 Jul; 2012():356362. PubMed ID: 22577247
    [Abstract] [Full Text] [Related]

  • 31. Resistin gene promoter region polymorphism and the risk of hypertrophic cardiomyopathy in patients.
    Hussain S, Asghar M, Javed Q.
    Transl Res; 2010 Mar; 155(3):142-7. PubMed ID: 20171599
    [Abstract] [Full Text] [Related]

  • 32. The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3.
    Osawa H, Yamada K, Onuma H, Murakami A, Ochi M, Kawata H, Nishimiya T, Niiya T, Shimizu I, Nishida W, Hashiramoto M, Kanatsuka A, Fujii Y, Ohashi J, Makino H.
    Am J Hum Genet; 2004 Oct; 75(4):678-86. PubMed ID: 15338456
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Association between four resistin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers.
    Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Ben Rejeb N, Nabli N, Ben Abdelaziz A, Bouslama A.
    Genet Test Mol Biomarkers; 2012 Dec; 16(12):1356-62. PubMed ID: 23020084
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Association of adiponectin and resistin gene polymorphisms in South Indian women with polycystic ovary syndrome.
    Nambiar V, Vijesh VV, Lakshmanan P, Sukumaran S, Suganthi R.
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():82-8. PubMed ID: 26995146
    [Abstract] [Full Text] [Related]

  • 37. Resistin -420C>G promoter variant and colorectal cancer risk.
    Mahmoudi T, Karimi K, Arkani M, Farahani H, Vahedi M, Dabiri R, Nobakht H, Asadi A, Mirakhorli M, Arshi B, Derakhshan A, Zali MR.
    Int J Biol Markers; 2014 Sep 30; 29(3):e233-8. PubMed ID: 24585435
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Hernández-Romero D, Orenes-Piñero E, García-Honrubia A, Climent V, Romero-Aniorte AI, Martínez CM, García-Bautista M, Martínez M, Feliu E, González J, Cánovas S, Montero-Argudo JA, Valdés M, Marín F.
    J Intern Med; 2015 Jul 30; 278(1):50-8. PubMed ID: 25476756
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.